Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYCLATOP: Topical Cyclosporine for Atopic Dermatitis
NCT02865356Phase 2Completed
- Sponsor
- Spherium Biomed
- Start
- Sep 2016
- Primary completion
- Apr 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Cyclatop in atopic dermatitis (AD), sponsored by Spherium Biomed. Started Sep 2016; status: completed.
02
Drugs
Cyclatop
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02865356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02865356.